Hemostatic and Nonhemostatic Effects of Heparan Sulfate Proteoglycans

Semin Thromb Hemost 2021; 47(03): 238-239
DOI: 10.1055/s-0041-1724119

Preface

Autor*innen

Yona Nadir

¹Thrombosis and Hemostasis Unit, Rambam Health Care Campus, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
Ton Lisman

²Department of Surgery, Surgical Research Laboratory, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands

References
1 Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002; 71: 435-471
2 Vlodavsky I, Barash U, Nguyen HM, Yang S-M, Ilan N. Biology of the heparanase-heparan sulfate axis an its role in disease pathogenesis. Semin Thromb Hemost 2021; 47 (03) 240-253
3 Nadir Y. Effect of heparanase and heparan sulfate chains in hemostasis. Semin Thromb Hemost 2021; 47 (03) 254-260
4 Hiebert LM. Heparan sulfate proteoglycans in diabetes. Semin Thromb Hemost 2021; 47 (03) 261-273
5 Oshima K, King SI, McMurtry SA, Schmidt EP. Endothelial heparan sulfate proteoglycans in sepsis: the role of the glycocalyx. Semin Thromb Hemost 2021; 47 (03) 274-282
6 Koganti R, Memon A, Shukla D. Emerging roles of heparan sulfate proteoglycans in viral pathogenesis. Semin Thromb Hemost 2021; 47 (03) 283-294
7 Lepedda AJ, Nieddu G, Piperigkou Z, Kyriakopoulou K, Karamanos N, Formato M. Circulating heparan sulfate proteoglycans as biomarkers in health and disease. Semin Thromb Hemost 2021; 47 (03) 295-307
8 Peall IW, Okolicsanyi RK, Griffiths LR, Haupt LM. 3D human neural stem cell models to mimic heparan sulfate proteoglycans (HSPGs) and the neural niche. Semin Thromb Hemost 2021; 47 (03) 308-315
9 Gerlza T, Trojacher C, Kitic N, Adage T, Kungl AJ. Development of molecules antagonizing heparan sulfate proteoglycans (HSPGs). Semin Thromb Hemost 2021; 47 (03) 316-332